-
From molecule to market and beyond: Uniphar announces extended global commercialization platform
Source: Pharmafile Published on 2024-10-25
-
Shawn Cross appointed as chief financial officer for Pacira Biosciences
Source: Pharmafile Published on 2024-10-25
-
Eplontersen recommended for EU approval by CHMP for treatment of hereditary transthyretin-mediated amyloidosis
Source: Pharmafile Published on 2024-10-21
-
Eli Lilly appoints new chief AI officer
Source: Pharmafile Published on 2024-10-17
-
FlyPharma Europe, Vienna – 23-24 October 2024 conference
Source: Pharmafile Published on 2024-10-14
-
Ferring demonstrates effectiveness of a treat-to-target approach in mild-to-moderate ulcerative colitis in first major study
Source: Pharmafile Published on 2024-10-03
-
Strategic alliance announced between Recipharm and Exela
Source: Pharmafile Published on 2024-10-01
-
Santhera Pharmaceuticals announces LIONHEART study results for corticosteroid vamorolone
Source: Pharmafile Published on 2024-10-01
-
Prilenia appoints new management staff to advance company’s development and commercialisation plans
Source: Pharmafile Published on 2024-09-30
-
Vertex Highlights First Oral Presentation of Phase 3 Clinical Dataof the Vanzacaftor Triple Combination and New Data on Long-Term Impact of TRIKAFTA at the North American CysticFibrosis Conference
Source: Pharmafile Published on 2024-09-30
-
Eli Lilly announces two senior hires in Public Affairs and Communications team
Source: Pharmafile Published on 2024-09-27
-
Laurence Reid and Brad Crutchfield appointed to Broken Strings’ board of directors
Source: Pharmafile Published on 2024-09-25
-
Third application for Orion’s prostate cancer drug submitted by partner Bayer
Source: Pharmafile Published on 2024-09-23
-
Expanded possibilities for laboratory digitalization and connectivity: labforward merges with LabTwin
Source: Pharmafile Published on 2024-09-19
-
Steriline’s founder “passes torch” to children with CEO and CSO appointments
Source: Pharmafile Published on 2024-09-19